Revenue and Profitability - Revenue for Q1 2022 was CNY 545,451,712.64, an increase of 19.86% year-over-year[2] - The total operating revenue for Q1 2022 was CNY 545,451,712.64, representing an increase of 19.87% compared to CNY 455,061,707.70 in Q1 2021[16] - The net profit for Q1 2022 was CNY 25,491,693.41, a decrease of 45.49% from CNY 46,776,485.03 in Q1 2021[17] - The total comprehensive income for Q1 2022 was CNY 25,466,412.63, down from CNY 46,082,081.49 in Q1 2021[18] - Net profit attributable to shareholders decreased by 45.73% to CNY 25,392,527.35 due to a decline in gross margin and increased R&D expenses[4] - Basic earnings per share decreased by 59.68% to CNY 0.25, primarily due to reduced net profit and an increase in the weighted average number of shares outstanding[4] Research and Development - R&D investment totaled CNY 26,244,155.26, representing 4.81% of revenue, an increase of 1.19 percentage points compared to the previous year[3] - Research and development expenses for Q1 2022 were CNY 26,244,155.26, up 59.00% from CNY 16,470,374.73 in Q1 2021[16] - The company experienced a significant increase in R&D efforts, leading to higher personnel and direct investment costs[5] - Research and development expenses increased to ¥23.78 million in Q1 2022 from ¥14.25 million in Q1 2021, marking a rise of 67.1%[30] Cash Flow and Liquidity - The net cash flow from operating activities was negative at CNY -112,488,871.57, attributed to increased payments to suppliers and employees[4] - Cash flow from operating activities showed a net outflow of ¥63.68 million in Q1 2022, worsening from a net outflow of ¥3.91 million in Q1 2021[30] - The cash flow from operating activities in Q1 2022 was CNY 539,774,194.26, compared to CNY 445,934,960.88 in Q1 2021[19] - The total cash and cash equivalents at the end of Q1 2022 were CNY 352,990,349.45, down from CNY 482,427,636.84 at the beginning of the period[21] - Cash and cash equivalents decreased to RMB 412,886,107.76 from RMB 505,422,668.84, indicating a decline of about 18.3%[11] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,366,592,162.67, a 6.62% increase from the end of the previous year[3] - The company's total liabilities as of Q1 2022 amounted to CNY 1,197,309,994.01, an increase from CNY 1,075,839,018.92 in the previous year[14] - The total assets as of March 31, 2022, amounted to CNY 2,240,754,263.66, an increase from CNY 2,097,878,540.64 at the end of 2021[25] - The total liabilities increased to CNY 1,072,999,106.62 from CNY 955,670,315.37 year-over-year[25] - Total current assets as of March 31, 2022, amounted to RMB 1,728,462,406.01, showing an increase from RMB 1,714,170,605.38 at the end of 2021[12] Shareholder Information - The company reported a total of 6,418 common shareholders at the end of the reporting period[6] - The top shareholder, Shenzhen Kunlun Dingtian Investment Co., Ltd., holds 42.25% of the shares[7] Future Outlook and Strategic Developments - The company has not disclosed any significant new product developments or market expansion strategies during the reporting period[10] - There were no significant mergers or acquisitions reported in the first quarter of 2022[10] - The company did not provide specific future guidance or performance outlook in the current report[10]
博力威(688345) - 2022 Q1 - 季度财报